Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Bumetanide
Drug ID BADD_D00307
Description Bumetanide is a sulfamyl diuretic.
Indications and Usage For the treatment of edema associated with congestive heart failure, hepatic and renal disease including the nephrotic syndrome.
Marketing Status approved
ATC Code C03CA02
DrugBank ID DB00887
KEGG ID D00247
MeSH ID D002034
PubChem ID 2471
TTD Drug ID D0R7HO
NDC Product Code 0832-0541; 60468-001; 72643-030; 0185-0129; 0641-6161; 0904-7016; 14501-0036; 17337-0055; 0185-0130; 50090-6137; 60687-535; 65219-570; 68382-526; 70518-3191; 71335-1692; 0641-6008; 17337-0011; 14539-702; 43353-288; 0185-0128; 50090-5666; 50090-6139; 50090-6345; 69238-1489; 70771-1025; 55154-4345; 65219-572; 68382-527; 69238-1491; 70518-2678; 72205-101; 0641-6162; 0832-0542; 55154-4733; 68462-469; 68462-470; 70860-405; 70860-406; 0615-8393; 0832-0540; 57755-0004; 63190-0370; 63190-0430; 42799-121; 50090-5068; 50090-5664; 70771-1026; 42799-120; 50090-5064; 50090-6138; 50268-132; 68083-497; 0409-1412; 14539-700; 50090-5663; 63629-4968; 68083-496; 72572-040; 72572-041; 60468-003; 42799-119; 50090-6308; 60687-384; 70771-1024; 72205-102; 0615-8394; 60468-002; 14539-701; 43353-292; 50090-6304; 50268-130; 50268-131; 55154-3572; 68382-525; 69238-1490; 0641-6007; 51662-1449
UNII 0Y2S3XUQ5H
Synonyms Bumetanide | Bumethanide | Bumex | PF-1593 | PF 1593 | PF1593 | Drenural | Fordiuran | Miccil | Bumedyl | Burinex
Chemical Information
Molecular Formula C17H20N2O5S
CAS Registry Number 28395-03-1
SMILES CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Musculoskeletal pain15.03.04.007--
Myalgia15.05.02.0010.016328%
Nausea07.01.07.001--
Nipple pain21.05.05.009--Not Available
Oedema peripheral14.05.06.011; 08.01.07.007; 02.05.04.0070.000282%
Orthostatic hypotension24.06.03.004; 17.05.01.0200.000282%Not Available
Pancreatitis07.18.01.001--
Polyuria20.02.03.0020.000706%Not Available
Premature ejaculation21.03.01.008; 19.08.01.002--Not Available
Protein total abnormal13.09.01.008--Not Available
Prothrombin time13.01.02.038--Not Available
Pruritus23.03.12.0010.000763%
Rash23.03.13.0010.000763%Not Available
Renal failure20.01.03.005--Not Available
Stevens-Johnson syndrome10.01.01.045; 23.03.01.007; 12.03.01.014; 11.07.01.005--
Syncope17.02.04.008; 02.11.04.015; 24.06.02.0120.000424%
Thrombocytopenia01.08.01.002--Not Available
Toxic epidermal necrolysis23.03.01.008; 12.03.01.015; 11.07.01.006; 10.01.01.006--
Urinary retention20.02.02.0110.000282%
Urticaria23.04.02.001; 10.01.06.0010.000763%
Vertigo17.02.12.002; 04.04.01.003--
Vomiting07.01.07.003--
White blood cell count13.01.06.027--Not Available
Hypoacusis04.02.01.006--
Peripheral swelling02.05.04.015; 08.01.03.0530.000621%Not Available
Ear discomfort04.03.01.005--Not Available
Protein urine present13.13.02.006--Not Available
Blood phosphorus abnormal13.11.01.017--Not Available
Blood bilirubin abnormal13.03.04.016--Not Available
Blood alkaline phosphatase abnormal13.04.02.005--Not Available
The 3th Page    First    Pre   3 4    Next   Last    Total 4 Pages